Andrew CPA - Sharps Technology Chief Officer
| STSS Stock | USD 1.85 0.03 1.60% |
Insider
Andrew CPA is Chief Officer of Sharps Technology
| Age | 68 |
| Address | 105 Maxess Road, Melville, NY, United States, 11747 |
| Phone | 631-574-4436 |
| Web | https://sharpstechnology.com |
Sharps Technology Management Efficiency
The company has return on total asset (ROA) of (0.5202) % which means that it has lost $0.5202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0321) %, meaning that it created substantial loss on money invested by shareholders. Sharps Technology's management efficiency ratios could be used to measure how well Sharps Technology manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.79 in 2025. Return On Capital Employed is likely to drop to -1.18 in 2025. At this time, Sharps Technology's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 8.4 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 2.1 M in 2025.Similar Executives
| Showing other executives | INSIDER Age | ||
| Yulin Wang | Meihua International Medical | 55 | |
| Josh Bennett | Repro Med Systems | N/A | |
| Thomas Ruiz | InfuSystems Holdings | 66 | |
| Daniel Habhegger | Precision Optics, | 54 | |
| BSN MBA | InfuSystems Holdings | 45 | |
| Joseph Forkey | Precision Optics, | 57 | |
| Richard Cyr | Precision Optics, | N/A | |
| Keith Schaefer | Avinger | N/A | |
| Lianzhang Zhao | Meihua International Medical | 57 | |
| Jeannine Sheehan | InfuSystems Holdings | 48 | |
| Richard Forkey | Precision Optics, | 85 | |
| David Stefansky | Nexgel Inc | 53 | |
| Pr DSc | Microbot Medical | 72 | |
| Donald Major | Precision Optics, | 63 | |
| Brian Case | Repro Med Systems | 51 | |
| Rachel Vaknin | Microbot Medical | 46 | |
| John Hargraves | Precision Optics, | N/A | |
| Keisha Harcum | Milestone Scientific | N/A | |
| Wang Xin | Meihua International Medical | 36 | |
| Tom Adams | Repro Med Systems | N/A | |
| Adam III | Nexgel Inc | 48 | |
Management Performance
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.52 |
Sharps Technology Leadership Team
Elected by the shareholders, the Sharps Technology's board of directors comprises two types of representatives: Sharps Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sharps. The board's role is to monitor Sharps Technology's management team and ensure that shareholders' interests are well served. Sharps Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sharps Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adam Holdsworth, Managing Director | ||
| Robert Hayes, CEO Director | ||
| Alan Blackman, Chief CoChairman | ||
| Steven MD, Chief Officer | ||
| Ben Scheu, Senior Sales | ||
| Barry Berler, Chief Inventor | ||
| Andrew CPA, Chief Officer |
Sharps Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sharps Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 3.65 M | ||||
| Shares Outstanding | 1.8 M | ||||
| Shares Owned By Insiders | 3.70 % | ||||
| Shares Owned By Institutions | 4.02 % | ||||
| Number Of Shares Shorted | 110.04 K | ||||
| Price To Book | 0.58 X | ||||
| EBITDA | (8.98 M) | ||||
| Net Income | (9.84 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sharps Stock Analysis
When running Sharps Technology's price analysis, check to measure Sharps Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sharps Technology is operating at the current time. Most of Sharps Technology's value examination focuses on studying past and present price action to predict the probability of Sharps Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sharps Technology's price. Additionally, you may evaluate how the addition of Sharps Technology to your portfolios can decrease your overall portfolio volatility.